Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+5.97%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$10.8B
AUM Growth
-$573M
(-5%)
Cap. Flow
-$872M
Cap. Flow
% of AUM
-8.04%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
577
New
157
Increased
112
Reduced
119
Closed
154
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$148M |
| 2 |
Skyworks Solutions
SWKS
|
+$122M |
| 3 |
Equitable Holdings
EQH
|
+$115M |
| 4 |
Target
TGT
|
+$113M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$109M |
Top Sells
| 1 |
IBM
IBM
|
+$155M |
| 2 |
NXP Semiconductors
NXPI
|
+$138M |
| 3 |
Salesforce
CRM
|
+$132M |
| 4 |
PF
Pinnacle Foods, Inc.
PF
|
+$120M |
| 5 |
Akamai
AKAM
|
+$114M |
Sector Composition
| 1 | Technology | 19.87% |
| 2 | Industrials | 16.28% |
| 3 | Energy | 11.93% |
| 4 | Financials | 11.89% |
| 5 | Healthcare | 11.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Hewlett Packard
HPE
$31.5B
| $1.38M | 0.01% |
94,429
-984,140
| -91% | -$14.4M |
|
|
GNCA
352
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.37M | 0.01% |
200,386
-28,965
| -13% | -$198K |
|
353
scPharmaceuticals
SCPH
$302M
| $1.31M | 0.01% |
230,819
+7,381
| +3% | +$41.8K |
|
354
Kezar Life Sciences
KZR
$29.4M
| $1.3M | 0.01% |
+7,500
| New | +$1.3M |
|
355
Owens Corning
OC
$12.5B
| $1.29M | 0.01% |
20,425
-54,721
| -73% | -$3.47M |
|
356
Armstrong World Industries
AWI
$8.4B
| $1.29M | 0.01% |
+20,466
| New | +$1.29M |
|
357
Electronic Arts
EA
$41.5B
| $1.26M | 0.01% |
+8,959
| New | +$1.26M |
|
|
OMED
358
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.23M | 0.01% |
534,309
+17,086
| +3% | +$39.5K |
|
359
Bread Financial
BFH
$3B
| $1.2M | 0.01% |
+6,433
| New | +$1.2M |
|
360
Healthcare Services Group
HCSG
$1.17B
| $1.17M | 0.01% |
+26,972
| New | +$1.17M |
|
|
UBX
361
DELISTED
Unity Biotechnology
UBX
| $1.14M | 0.01% |
+7,588
| New | +$1.14M |
|
362
Cencora
COR
$57.9B
| $1.11M | 0.01% |
+13,044
| New | +$1.11M |
|
363
Astria Therapeutics
ATXS
$425M
| $1.08M | 0.01% |
18,692
+16,732
| +854% | +$963K |
|
364
Arcus Biosciences
RCUS
$1.2B
| $1.08M | 0.01% |
87,808
+2,808
| +3% | +$34.4K |
|
365
Aurinia Pharmaceuticals
AUPH
$1.63B
| $1.06M | 0.01% |
188,709
-387,615
| -67% | -$2.18M |
|
|
ADMS
366
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.03M | 0.01% |
39,827
+1,274
| +3% | +$32.9K |
|
367
Idexx Laboratories
IDXX
$52.5B
| $1.03M | 0.01% |
+4,707
| New | +$1.03M |
|
|
HTGM
368
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $978K | 0.01% |
+1,667
| New | +$978K |
|
369
Akebia Therapeutics
AKBA
$795M
| $975K | 0.01% |
97,734
-4,701
| -5% | -$46.9K |
|
|
EVFM
370
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $963K | 0.01% |
+23,695
| New | +$963K |
|
|
DERM
371
DELISTED
Dermira, Inc.
DERM
| $952K | 0.01% |
103,465
+3,309
| +3% | +$30.4K |
|
|
VIVE
372
DELISTED
VIVEVE MED INC
VIVE
| $876K | 0.01% |
322
-581
| -64% | -$1.58M |
|
|
FSCT
373
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $857K | 0.01% |
25,000
-155,000
| -86% | -$5.31M |
|
374
electroCore
ECOR
$38.5M
| $826K | 0.01% |
+3,337
| New | +$826K |
|
|
NBRV
375
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $765K | 0.01% |
880
-2,293
| -72% | -$1.99M |
|